Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H11N |
Molecular Weight | 85.1475 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCC1
InChI
InChIKey=AVFZOVWCLRSYKC-UHFFFAOYSA-N
InChI=1S/C5H11N/c1-6-4-2-3-5-6/h2-5H2,1H3
Molecular Formula | C5H11N |
Molecular Weight | 85.1475 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
O-Phosphonatomethylcholine, its analogues, alkyl esters, and their biological activity. | 2001 Dec 6 |
|
Some aspects of NaBH(4) reduction in NMP. | 2002 Aug |
|
Studies on a soft glycopyrrolate analog, SG-1. | 2002 Feb |
|
N-methylpiperidinemethyl, N-methylpyrrolidyl and N-methylpyrrolidinemethyl esters as PET radiotracers for acetylcholinesterase activity. | 2003 Apr |
|
Kinetics and mechanism of ring transformation of S-[1-(4-methoxyphenyl)pyrrolidin-2-on-3-yl]isothiuronium bromide to 2-methylimino-5-[2-(4-methoxyphenylamino)ethyl]thiazolidin-4-one. | 2003 Apr 7 |
|
A new highly asymmetric chelation-controlled heck arylation. | 2003 Mar 26 |
|
A simple and sensitive GC method for determination of N-methylpyrrolidine in cefepime and its preparation. | 2003 Nov 24 |
|
Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shielding. | 2003 Oct |
|
N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices. | 2003 Sep |
|
Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. | 2004 Feb 15 |
|
A new class of potent non-imidazole H(3) antagonists: 2-aminoethylbenzofurans. | 2004 Feb 9 |
|
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. | 2004 Jan 19 |
|
5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. | 2005 Jan 13 |
|
Synthesis of new, potent avermectin-like insecticidal agents. | 2005 Jul 4 |
|
Direct synthesis of fused 1,2,3,4,5-pentathiepins. | 2005 Oct 7 |
|
A nonradioactive high-throughput/high-content assay for measurement of the human serotonin reuptake transporter function in vitro. | 2006 Dec |
|
Glyoxalase I-type hemithioacetal isomerization reactivity of a mononuclear Ni(II) deprotonated amide complex. | 2006 Dec 27 |
|
EPR studies of amine radical cations. Part 2. Thermal and photo-induced rearrangements of propargylamine and allylamine radical cations in low-temperature freon matrices. | 2006 Dec 28 |
|
Modeling proline ligation in the heme-dependent CO sensor, CooA, using small-molecule analogs. | 2006 Jul |
|
Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits. | 2006 Jun |
|
Electrokinetic chromatographic characterization of novel pseudo-phases based on N-alkyl-N-methylpyrrolidinium ionic liquid type surfactants. | 2006 Nov |
|
Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. | 2006 Nov 30 |
|
The synthesis of N,O-ferrocenyl pyrrolidine-containing ligands and their application in the diethyl- and diphenylzinc addition to aromatic aldehydes. | 2006 Sep 29 |
|
Nicotine: on the potential role of ionic liquids for its processing and purification. | 2007 Jul 19 |
|
Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases. | 2007 Jun |
|
Abstracts of papers presented at the 2008 pittsburgh conference. | 2008 |
|
1-Methyl-1-propyl-pyrrolidinium chloride. | 2008 Feb 29 |
|
1,1'-Dimethyl-1,1'-(butane-1,4-di-yl)dipyrrolidinium dibromide methanol disolvate. | 2008 Jan 11 |
|
An improved ion chromatographic method for fast and sensitive determination of N-methylpyrrolidine in cefepime hydrochloride. | 2009 Aug |
|
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity. | 2009 Feb 1 |
|
Selective triplet-state formation during charge recombination in a fullerene/Bodipy molecular dyad (Bodipy=borondipyrromethene). | 2009 Jul 27 |
|
Using the cationic surfactants N-cetyl-N-methylpyrrolidinium bromide and 1-cetyl-3-methylimidazolium bromide for sweeping-micellar electrokinetic chromatography. | 2009 Jul 3 |
|
Formation and properties of stabilized aluminum nanoparticles. | 2009 Mar |
|
Evaluation of Pharmasolve corneal permeability enhancement and its irritation on rabbit eyes. | 2009 May |
|
Pyrrolidinium ionic liquid crystals with pendant mesogenic groups. | 2009 May 19 |
|
Prospective monitoring of cefepime in intensive care unit adult patients. | 2010 |
|
A simple and rapid dispersive liquid-liquid microextraction method followed by GC-FID for determination of N-methylpyrrolidine in cefepime. | 2010 Dec |
|
Validation of capillary electrophoresis method for determination of N-methylpyrrolidine in cefepime for injection. | 2010 Nov |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:47:24 GMT 2023
by
admin
on
Fri Dec 15 17:47:24 GMT 2023
|
Record UNII |
06509TZU6C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
204-438-5
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY | |||
|
DTXSID8042210
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY | |||
|
8454
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY | |||
|
65
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY | |||
|
120-94-5
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY | |||
|
06509TZU6C
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY | |||
|
65579
Created by
admin on Fri Dec 15 17:47:24 GMT 2023 , Edited by admin on Fri Dec 15 17:47:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
Converted rapidly to NMP-N-oxide
MINOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|